to contribute to unexpected mortality. [7] Medication errors are broadly defined as any error in the prescribing, dispensing or administration of a drug, irrespective of whether such errors lead to adverse consequences or not. They are a growing problem in the UK, although estimates can differ due to the variety of criteria and definitions used: hospital incidence of medication errors may range from 4.4 to 6.2 events per 100 admissions. The NPSA has identified that certain key drug classes -antibiotics, painkillers and sedatives -are likely to be the most common types associated with medication error. The National Patient Safety campaign has identified anticoagulants, narcotics, insulin and sedatives as high-risk medicines, with intravenous drug administration being a particular target. How strong and robust are our reporting systems? The evidence is clear that we are underestimating the extent of the problem. Medication errors are the single most preventable cause of patient harm. The landmark Institute of Medicine report, To Err is Human: Building a Safer Health System, [8, 9] estimated that errors in medical management lead to between 44 000 and 98 000 deaths in the US each year, although these figures have been questioned. Incident rates of medication errors vary widely, the reason for which can be explained by the different study methods and definitions used. The rate of medication errors varies between 2 and 14% of patients admitted to hospital, with 1-2% of patients in the US being harmed as a result, and the majority are due to poor prescribing. Medication error has been estimated to kill 7000 patients per annum and accounts for nearly one in 20 hospital admissions in the US. The incidence is similar in the UK. Medication errors (7% of all incidents) were the second most common incident reported (after patient falls) in a recent National Audit Office report [10] on patient safety. Pharmacy services need a comprehensive and effective way to identify events that do cause harm to patients. Perhaps we should be fully integrating the Institute of Health Improvement Global Trigger Tool, which is intended to be used to identify all categories of adverse events including those related to medications. [11] The history of the development of clinical pharmacy, pharmaceutical care and medicines management put the pharmacist in a unique position to play a lead role in patient safety by ensuring medication safety for patients. Fundamental to our role is ensuring we have rational and effective guidelines and formulary management systems. What is sad is that work in the late 1980s and early 1990s recognized the importance of formulary management of antibiotic prescribing, yet it is only over the past few years that organizations have embedded antibiotic prescribing policies to manage the risks of MRSA and Clostridium difficile. Pharmacists need to ensure that patients can manage their medicines effectively though their role in the drug-use process. Practice research has now provided an evidence base which shows how electronic prescribing. medicines reconciliation and pharmaceutical care in discharge planning can ensure the effectiveness and safety of medicines use. However, in 2008 we are only now starting to develop the IT infrastructure for electronic prescribing and discharge, we have not embedded effective pharmaceutical care in discharge-management processes, and still patients do not take their medicines appropriately and have significant medication-related problems. Pharmacy developments must now implement more effectively our service principles and goals of delivering pharmaceutical care to ensure that patients are safe and to achieve effective health outcomes. Pharmacists must not take 20 years to embrace patient safety tools. Managers must play a crucial leadership role in creating a culture of patient safety which transforms the delivery of effective pharmaceutical services, putting patient safety as the number one priority.
